Filing Details
- Accession Number:
- 0001193125-16-517968
- Form Type:
- 13G Filing
- Publication Date:
- 2016-03-25 12:59:01
- Filed By:
- Petercam (luxembourg) S.a.
- Company:
- Apyx Medical Corp (NASDAQ:APYX)
- Filing Date:
- 2016-03-25
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Petercam (Luxembourg) S.A | 0 | 2,015,000 | 0 | 2,015,000 | 2,015,000 | 7.4% |
| Petercam Horizon L Country Sector Discounted Assets | 0 | 2,015,000 | 0 | 2,015,000 | 2,015,000 | 7.4% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
BOVIE MEDICAL CORPORATION
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
10211F100
(CUSIP Number)
December 31, 2015
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 10211F100 | 13G | Page 2 of 6 Pages |
| 1. | NAMES OF REPORTING PERSONS
Petercam (Luxembourg) S.A. | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ (b) x
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Luxembourg | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
2,015,000 | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
2,015,000 | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,015,000 | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)
¨ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.4% (1) | |||||
| 12. | TYPE OF REPORTING PERSON (see instructions)
FI | |||||
| (1) | The percentage set forth in Row 11 of this Cover Page is based on the 27,194,251 shares of Common Stock (as defined herein) of the Issuer (as defined herein) outstanding as of November 4, 2015, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015. |
| CUSIP No. 10211F100 | 13G | Page 3 of 6 Pages |
| 1. | NAMES OF REPORTING PERSONS
Petercam Horizon L Country & Sector Discounted Assets | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ (b) x
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Luxembourg | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
2,015,000 | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
2,015,000 | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,015,000 | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)
¨ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.4% (1) | |||||
| 12. | TYPE OF REPORTING PERSON (see instructions)
FI | |||||
| (1) | The percentage set forth in Row 11 of this Cover Page is based on the 27,194,251 shares of Common Stock of the Issuer outstanding as of November 4, 2015, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015. |
| CUSIP No. 10211F100 | 13G | Page 4 of 6 Pages |
Item 1.
| (a) | Name of Issuer |
Bovie Medical Corporation
| (b) | Address of Issuers principal executive offices |
| 4 Manhattanville Road, Suite 106, Purchase, NY 10577 |
Item 2.
| (a) | Name of person filing |
This Schedule 13G is being filed on behalf of Petercam (Luxembourg) S.A. (Petercam) and Petercam Horizon L Country & Sector Discounted Assets (Horizon L) with respect to the shares of Common Stock, $0.001 par value per share (the Common Stock), of Bovie Medical Corporation, a Delaware corporation (the Issuer).
Petercam acts as investment manager with respect to, and exercises investment discretion with respect to the Common Stock directly owned by, a number of private investment funds, including Horizon L, a Luxembourg corporation.
The filing of this statement should not be construed as an admission that Petercam is, for the purpose of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.
| (b) | Address or principal business office or, if none, residence |
The address of (i) Petercam is Rue Pierre dAspelt 1a, L-1142 Luxembourg and (ii) Horizon L is 14, Boulevard Royal, L-2449 Luxembourg.
| (c) | Citizenship |
See Row 4 of each Cover Page.
| (d) | Title of class of securities |
Common Stock, par value $0.001 per share
| (e) | CUSIP No. |
10211F100
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
| (a) | ¨ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | ||
| (b) | ¨ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | ||
| (c) | ¨ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | ||
| (d) | ¨ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | ||
| (e) | ¨ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | ||
| (f) | ¨ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | ||
| (g) | ¨ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | ||
| (h) | ¨ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | ||
| (i) | ¨ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | ||
| (j) | x | A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); | ||
| (k) | ¨ | Group, in accordance with §240.13d-1(b)(1)(ii)(K). | ||
| CUSIP No. 10211F100 | 13G | Page 5 of 6 Pages |
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:
Petercam is comparable to an IA and Horizon L is comparable to a CO.
Item 4. Ownership.
The information required by Items 4(a)-(c) is set forth in Rows 5-11 of each Cover Page and is incorporated herein by reference.
Petercam expressly declares that this filing shall not be construed as an admission that it is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this filing.
Item 5. Ownership of 5 Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than 5 Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
| CUSIP No. 10211F100 | 13G | Page 6 of 6 Pages |
SIGNATURES
After reasonable inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
DATED: March 25, 2016
PETERCAM (LUXEMBOURG) S.A.
| By: | /s/ Gaetan van der Bruggen | |
| Gaetan van der Bruggen, Member of the Management Board | ||
PETERCAM HORIZON L COUNTRY & SECTOR DISCOUNTED ASSETS
| By: | /s/ Jérôme Castagne | |
| Jérôme Castagne, Director | ||
Exhibit 1
JOINT FILING AGREEMENT
PURSUANT TO SECTION 240.13D-1 (K)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that it knows or has reason to believe that such information is inaccurate.
| PETERCAM (LUXEMBOURG) S.A. | ||
| By: | /s/ Gaetan van der Bruggen | |
| Gaetan van der Bruggen, Member of the Management Board | ||
| PETERCAM HORIZON L COUNTRY & SECTOR DISCOUNTED ASSETS | ||
| By: | /s/ Jérôme Castagne | |
| Jérôme Castagne, Director | ||